Navigation Links
DrugRisk Adds Update on Stryker Hip Recall: Claims Could Cost $190 to 390 Million
Date:3/29/2013

Chicago, IL (PRWEB) March 29, 2013

The hip implant resource center at DrugRisk.com is announcing new information on the site for patients that may have been affected by the recent Stryker hip recall. The company has informed investors they are attempting to resolve claims as patients alleging injury have requested cases be moved to a federal court.

DrugRisk was created to provide patients using popular drugs and medical devices with the latest warnings, recalls, studies and litigation news. Visitors can learn if others are experiencing similar side effects and decide if they need legal advice.

The resource center contains warnings from the British Medical Journal* and FDA** that toxic metal shavings from all-metal hips like the Stryker ABG II and Rejuvenate can cause serious conditions such as tissue damage, bone loss and damage to other organs when released into the body.

Stryker issued a recall of the Rejuvenate and ABG II modular implant systems in July of 2012***. As part of the recall, the company admitted some patients experienced adverse local tissue reactions or elevated levels of metal in the bloodstream, even if no symptoms were present***.

So far, more than 80 patients affected by the hip recall have filed Stryker lawsuits in a New Jersey multi-district court****.

DrugRisk has also learned that patients filed a petition with the U.S. Judicial Panel on Multidistrict Litigation asking that Stryker lawsuits be consolidated to a special federal court in the U.S. District Court, District of Minnesota. (In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, Case Pending No. 20 (JPML))

Now, Stryker has advised investors that costs associated with legal claims over the hip recall may amount to between $190 and $390 million*****.

Anyone that may have been affected by the Stryker Rejuvenate or ABG II hip recall is urged to contact the DrugRisk Resource Center or speak with a lawyer about their full legal rights before signing anything from the company.

Due to the specialized nature of federal medical device injury cases, DrugRisk only recommends lawyers and law firms who have already handled Stryker recall lawsuits.

For more information on the recall, studies and litigation news related to Stryker or other metal hips, or to speak with a lawyer, visit http://www.DrugRisk.com.

*bmj.com/content/344/bmj.e1410
**fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm
***stryker.com/en-us/products/Orthopaedics/modularneckstems/index.htm
****northjersey.com/mahwah/Over_80_lawsuits_on_hip_implants_filed_against_Mahwah-based_Stryker_Orthopaedics_.html?page=all
*****Stryker 2012 Annual Report, Other Information, Legal and Regulatory Matters, Pg. 19; http://catalog.e-digitaleditions.com/i/114936

Read the full story at http://www.prweb.com/releases/stryker-hip-lawsuit/litigation-news/prweb10581679.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Center Adds Latest on First of 3,000 Actos Bladder Cancer Trials
2. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
3. DrugRisk Update: New Pradaxa Study Questions FDA Safety Conclusion
4. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
5. DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
6. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
7. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
8. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
9. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
10. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
11. DrugRisk Announces New Pradaxa Health Warning From Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... The Topricin Companies, ... awareness for Topricin’s revolutionary, natural, after-burn skin care product, Topricin After Burn Cream. ... of long term skin conditions, including cancer. In the short term, overexposure ...
(Date:7/24/2017)... ... 24, 2017 , ... A CDC study shows that, although people are taking more steps to ... 29), had at least one case of sunburn within the past year. It’s common and ... ignore the issue. However, only recently have people become conscientious of the risks that accompany ...
(Date:7/24/2017)... ... 2017 , ... Anyone who uses scales know they have limits; a small ... that same scale to dispense medication. The first example is an issue of capacity, ... it is important to have the right balance for the process. METTLER TOLEDO’s new ...
(Date:7/24/2017)... OR (PRWEB) , ... July 24, 2017 , ... Sharon ... Climate Change and Your Health on VoiceAmerica sponsored by Nature’s Tears® EyeMist® recently talked ... the rise of myopia in China. , The article by Zidor Aldama described the ...
(Date:7/24/2017)... ... July 24, 2017 , ... Paul Vitenas, MD, FACS is excited to report ... invited to attend Allergan’s recent meeting with their Plastics Advisory Board. As one of ... Allergan is bringing a newly defined structure to the aesthetics market. Dr. Vitenas ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017  Sysmex America, ... urinalysis diagnostic testing equipment as well as middleware ... a way to make quality assurance easier and ... "Sysmex is well known for the innovation that ... Quality Monitor elevates quality assurance processes to a ...
(Date:7/10/2017)... , July 10, 2017  BDI Group subsidiary ... patient support services organization serving specialty pharmacies, home ... launch of four significant, value-added member programs designed ... better manage reimbursement and improve access and affordability ... therapies. ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... company focused on the development of oral drug delivery systems, ... Securities Authority to dual-list its common stock on the Tel ... on the TASE on July 12, 2017 under the ticker ... it is expected that Oramed will be included in the ...
Breaking Medicine Technology: